Mark A. Farrow

992 total citations
17 papers, 772 citations indexed

About

Mark A. Farrow is a scholar working on Molecular Biology, Physiology and Nutrition and Dietetics. According to data from OpenAlex, Mark A. Farrow has authored 17 papers receiving a total of 772 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 6 papers in Physiology and 6 papers in Nutrition and Dietetics. Recurrent topics in Mark A. Farrow's work include Prion Diseases and Protein Misfolding (8 papers), Alzheimer's disease research and treatments (6 papers) and Trace Elements in Health (6 papers). Mark A. Farrow is often cited by papers focused on Prion Diseases and Protein Misfolding (8 papers), Alzheimer's disease research and treatments (6 papers) and Trace Elements in Health (6 papers). Mark A. Farrow collaborates with scholars based in United Kingdom, United States and Ireland. Mark A. Farrow's co-authors include John Collinge, Dominic M. Walsh, Andrew J. Nicoll, Emmanuel Risse, Silvia Panico, Darragh B. Freir, Helen R. Saibil, Richard B. Sessions, Anthony R. Clarke and Paul Schimmel and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Mark A. Farrow

16 papers receiving 763 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark A. Farrow United Kingdom 11 605 415 209 148 87 17 772
Krzysztof Nieznański Poland 18 628 1.0× 304 0.7× 195 0.9× 109 0.7× 61 0.7× 31 814
Emmanuel Risse United Kingdom 8 501 0.8× 568 1.4× 221 1.1× 141 1.0× 119 1.4× 10 790
Rodrigo Díaz‐Espinoza Chile 14 607 1.0× 377 0.9× 215 1.0× 125 0.8× 39 0.4× 22 808
Chae Kim United States 15 569 0.9× 288 0.7× 279 1.3× 138 0.9× 52 0.6× 23 698
Raffaella Capobianco Italy 12 336 0.6× 330 0.8× 189 0.9× 77 0.5× 86 1.0× 18 574
Silvia Panico United Kingdom 7 394 0.7× 318 0.8× 160 0.8× 130 0.9× 70 0.8× 7 492
Genevieve M Klug Australia 13 777 1.3× 276 0.7× 339 1.6× 193 1.3× 50 0.6× 33 973
Marcella Catania Italy 14 418 0.7× 416 1.0× 167 0.8× 46 0.3× 100 1.1× 31 730
P. E. Fraser Canada 6 368 0.6× 236 0.6× 154 0.7× 94 0.6× 41 0.5× 7 510
Tracy Haldiman United States 12 502 0.8× 261 0.6× 237 1.1× 119 0.8× 41 0.5× 18 607

Countries citing papers authored by Mark A. Farrow

Since Specialization
Citations

This map shows the geographic impact of Mark A. Farrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Farrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Farrow more than expected).

Fields of papers citing papers by Mark A. Farrow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Farrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Farrow. The network helps show where Mark A. Farrow may publish in the future.

Co-authorship network of co-authors of Mark A. Farrow

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Farrow. A scholar is included among the top collaborators of Mark A. Farrow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Farrow. Mark A. Farrow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Serrano-Benítez, Almudena, Lilian C. Russo, Mark A. Farrow, et al.. (2023). Unrepaired base excision repair intermediates in template DNA strands trigger replication fork collapse and PARP inhibitor sensitivity. The EMBO Journal. 42(18). e113190–e113190. 22 indexed citations
2.
Purro, Silvia A., Michael Farmer, Claire J. Sarell, et al.. (2023). Two mouse models of Alzheimer’s disease accumulate amyloid at different rates and have distinct Aβ oligomer profiles unaltered by ablation of cellular prion protein. PLoS ONE. 18(11). e0294465–e0294465. 2 indexed citations
3.
Purro, Silvia A., Mark A. Farrow, Jacqueline M. Linehan, et al.. (2018). Transmission of amyloid-β protein pathology from cadaveric pituitary growth hormone. Nature. 564(7736). 415–419. 118 indexed citations
4.
Sarell, Claire J., Cassandra Terry, Andrew J. Nicoll, et al.. (2017). Soluble Aβ aggregates can inhibit prion propagation. Open Biology. 7(11). 8 indexed citations
5.
Risse, Emmanuel, Andrew J. Nicoll, William A. Taylor, et al.. (2015). Identification of a Compound That Disrupts Binding of Amyloid-β to the Prion Protein Using a Novel Fluorescence-based Assay. Journal of Biological Chemistry. 290(27). 17020–17028. 30 indexed citations
6.
O’Driscoll, Michael, et al.. (2015). Extending Anchor Handling Vessel Capabilities and the Technical Innovations that Make it Possible. Offshore Technology Conference.
7.
Nicoll, Andrew J., Silvia Panico, Darragh B. Freir, et al.. (2013). Amyloid-β nanotubes are associated with prion protein-dependent synaptotoxicity. Nature Communications. 4(1). 2416–2416. 104 indexed citations
8.
Klöhn, Peter‐Christian, Michael Farmer, Jacqueline M. Linehan, et al.. (2012). PrP Antibodies Do Not Trigger Mouse Hippocampal Neuron Apoptosis. Science. 335(6064). 52–52. 55 indexed citations
9.
Freir, Darragh B., Andrew J. Nicoll, Igor Klyubin, et al.. (2011). Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sites. Nature Communications. 2(1). 336–336. 243 indexed citations
10.
Nicoll, Andrew J., Clare R. Trevitt, M. Howard Tattum, et al.. (2010). Pharmacological chaperone for the structured domain of human prion protein. Proceedings of the National Academy of Sciences. 107(41). 17610–17615. 62 indexed citations
11.
Farrow, Mark A. & Paul Schimmel. (2001). Editing by a tRNA Synthetase:  DNA Aptamer-Induced Translocation and Hydrolysis of a Misactivated Amino Acid. Biochemistry. 40(14). 4478–4483. 4 indexed citations
12.
Fàbrega, Carme, Mark A. Farrow, Biswarup Mukhopadhyay, et al.. (2001). An aminoacyl tRNA synthetase whose sequence fits into neither of the two known classes. Nature. 411(6833). 110–114. 43 indexed citations
13.
Farrow, Mark A., Brian E. Nordin, & Paul Schimmel. (1999). Nucleotide Determinants for tRNA-Dependent Amino Acid Discrimination by a Class I tRNA Synthetase. Biochemistry. 38(51). 16898–16903. 29 indexed citations
14.
Farrow, Mark A., Fareed Aboul‐ela, David Owen, et al.. (1998). Site-Specific Cross-Linking of Amino Acids in the Basic Region of Human Immunodeficiency Virus Type 1 Tat Peptide to Chemically Modified TAR RNA Duplexes. Biochemistry. 37(9). 3096–3108. 20 indexed citations
16.
Adams, C.J., James B. Murray, Mark A. Farrow, John R. P. Arnold, & Peter G. Stockley. (1995). Incorporation of 6-thioguanosine into oligoribonucleotides. Tetrahedron Letters. 36(30). 5421–5424. 2 indexed citations
17.
Adams, C.J., Mark A. Farrow, James B. Murray, et al.. (1995). Incorporation of 6-thioinosine into oligoribonucleotides. Tetrahedron Letters. 36(26). 4637–4640. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026